肥厚性心肌病的最新指南.pptVIP

Pharmacologic Management Nifedipine or other dihydropyridine calcium channel-blocking drugs are potentially harmful for treatment of symptoms (angina or dyspnea) in patients with HCM who have resting or provocable LVOT obstruction. 对有静息或可激发的LVOT梗阻的HCM患者，用硝苯地平或其它二氢吡啶类钙通道阻滞剂治疗（心绞痛或呼吸困难）症状潜在危害。 Verapamil is potentially harmful in patients with obstructive HCM in the setting of systemic hypotension or severe dyspnea at rest. 对有低血压或严重静息呼吸困难的梗阻性HCM患者，维拉帕米有潜在的危害。 Digitalis is potentially harmful in the treatment of dyspnea in patients with HCM and in the absence of AF. 对没有心房颤动的HCM患者，用洋地黄治疗呼吸困难可能有害。